litlas
ログインアカウント作成

Peter Altevogt

1982–2025 年に発表

115
論文数
21,121
被引用数
84
h 指数
107
i10 指数

被引用数

Peter Altevogt の年別被引用数1978 年: 被引用 1 件1982 年: 被引用 1 件1983 年: 被引用 4 件1984 年: 被引用 6 件1985 年: 被引用 4 件1986 年: 被引用 5 件1987 年: 被引用 4 件1988 年: 被引用 4 件1989 年: 被引用 3 件1990 年: 被引用 15 件1991 年: 被引用 26 件1992 年: 被引用 40 件1993 年: 被引用 24 件1994 年: 被引用 19 件1995 年: 被引用 40 件1996 年: 被引用 36 件1997 年: 被引用 42 件1998 年: 被引用 38 件1999 年: 被引用 50 件2000 年: 被引用 41 件2001 年: 被引用 61 件2002 年: 被引用 90 件2003 年: 被引用 87 件2004 年: 被引用 80 件2005 年: 被引用 91 件2006 年: 被引用 140 件2007 年: 被引用 155 件2008 年: 被引用 157 件2009 年: 被引用 163 件2010 年: 被引用 152 件2011 年: 被引用 169 件2012 年: 被引用 226 件2013 年: 被引用 211 件2014 年: 被引用 250 件2015 年: 被引用 268 件2016 年: 被引用 349 件2017 年: 被引用 307 件2018 年: 被引用 308 件2019 年: 被引用 866 件2020 年: 被引用 1,057 件2021 年: 被引用 947 件2022 年: 被引用 792 件2023 年: 被引用 591 件2024 年: 被引用 829 件2025 年: 被引用 379 件2026 年: 被引用 4 件1979〜1981 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,269 件、この内訳の 22.8%中国: 引用元論文 1,468 件、この内訳の 14.8%ドイツ: 引用元論文 715 件、この内訳の 7.2%イタリア: 引用元論文 473 件、この内訳の 4.7%イギリス: 引用元論文 418 件、この内訳の 4.2%オーストラリア: 引用元論文 318 件、この内訳の 3.2%フランス: 引用元論文 295 件、この内訳の 3%日本: 引用元論文 278 件、この内訳の 2.8%カナダ: 引用元論文 267 件、この内訳の 2.7%スペイン: 引用元論文 245 件、この内訳の 2.5%オランダ: 引用元論文 231 件、この内訳の 2.3%韓国: 引用元論文 216 件、この内訳の 2.2%
0%22.8%その他 27.6%

機関

分野

  • Biochemistry, Genetics and Molecular Biology53.3%
  • Medicine27.4%
  • Immunology and Microbiology13.6%
  • Neuroscience2.7%
  • Engineering0.9%
  • Materials Science0.5%
  • その他1.6%

トピック

  • Extracellular vesicles in disease13.4%
  • MicroRNA in disease regulation8%
  • Immune cells in cancer4.3%
  • Cancer Immunotherapy and Biomarkers3.2%
  • RNA Interference and Gene Delivery2.8%
  • Immunotherapy and Immune Responses2.7%
  • その他65.6%

共著者

全論文

検索で開く
  1. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression

    著者: Christopher Groth, Xiaoying Hu, Rebekka Weber, Viktor Fleming, Peter Altevogt, Jochen Utikal, Viktor Umansky - British Journal of Cancer 2018 被引用: 817

  2. Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation

    著者: Hina Kalra, Richard J. Simpson, Hong Ji, Elena Aïkawa, Peter Altevogt, Philip W. Askenase, Vincent C. Bond, Francesc E. Borràs, Xandra O. Breakefield, Vivian Budnik, Edit I. Buzás, Giovanni Camussi, Aled Clayton, Emanuele Cocucci, Juan Manuel Falcón‐Pérez, Susanne Gabrielsson, Yong Song Gho, Dwijendra K. Gupta, H. C. Harsha, An Hendrix, Andrew F. Hill, Jameel M. Inal, Guido Jenster, Eva‐Maria Krämer‐Albers, Sai Kiang Lim, Alicia Llorente, Jan Lötvall, Antonio Marcilla, Lucia Mincheva‐Nilsson, Irina Nazarenko, Rienk Nieuwland, Esther N. M. Nolte-‘t Hoen, Akhilesh Pandey, Tushar Patel, Melissa Piper, Stefano Pluchino, Thottethodi Subrahmanya Keshava Prasad, Lawrence Rajendran, Graça Raposo, Michel Record, Gavin E. Reid, Francisco Sánchez‐Madrid, Raymond M. Schiffelers, Pia Siljander, Allan Stensballe, Willem Stoorvogel, Douglas D. Taylor, Clotilde Théry, Hadi Valadi, Bas W. M. van Balkom, Jesús Vázquez, Michel Vidal, Marca H. M. Wauben, María Yáñez‐Mó, Margot Zoeller, Suresh Mathivanan - PLoS Biology 2012 被引用: 1,363

  3. IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy

    著者: Rebekka Weber, Christopher Groth, Samantha Lasser, Ihor Arkhypov, Vera Petrova, Peter Altevogt, Jochen Utikal, Viktor Umansky - Cellular Immunology 2020 被引用: 312

  4. Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors

    著者: Rebekka Weber, Viktor Fleming, Xiaoying Hu, Vasyl S. Nagibin, Christopher Groth, Peter Altevogt, Jochen Utikal, Viktor Umansky - Frontiers in Immunology 2018 被引用: 551

  5. Interaction and uptake of exosomes by ovarian cancer cells

    著者: Cristina Escrevente, Sascha Keller, Peter Altevogt, Júlia Costa - BMC Cancer 2011 被引用: 667

  6. Extracellular Vesicle-Mediated Transfer of Genetic Information between the Hematopoietic System and the Brain in Response to Inflammation

    著者: Kirsten De Ridder, Sascha Keller, Maria Dams, Anne-Kathleen Rupp, Jessica Schlaudraff, Domenico Del Turco, Julia Starmann, Jadranka Macas, Darja Karpova, Kavi Devraj, Candan Depboylu, Britta Landfried, Bernd Arnold, Karl H. Plate, Günter U. Höglinger, Holger Sültmann, Peter Altevogt, Stefan Momma - PLoS Biology 2014 被引用: 417

  7. SOX2 in development and cancer biology

    著者: Daniel Novak, Laura Hüser, Jonathan J. Elton, Viktor Umansky, Peter Altevogt, Jochen Utikal - Seminars in Cancer Biology 2019 被引用: 389

  8. Novel insights into the function of CD24: A driving force in cancer

    著者: Peter Altevogt, Marei Sammar, Laura Hüser, Glen Kristiansen - International Journal of Cancer 2020 被引用: 201

  9. Body fluid derived exosomes as a novel template for clinical diagnostics

    著者: Sascha Keller, Johannes Ridinger, Anne-Kathleen Rupp, Johannes W.G. Janssen, Peter Altevogt - Journal of Translational Medicine 2011 被引用: 758

  10. Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression

    著者: Viktor Fleming, Xiaoying Hu, Rebekka Weber, Vasyl S. Nagibin, Christopher Groth, Peter Altevogt, Jochen Utikal, Viktor Umansky - Frontiers in Immunology 2018 被引用: 455

  11. CCR5+ Myeloid-Derived Suppressor Cells Are Enriched and Activated in Melanoma Lesions

    著者: C Blattner, Viktor Fleming, Rebekka Weber, Bianca Himmelhan, Peter Altevogt, Christoffer Gebhardt, Torsten J. Schulze, Hila Razon, Elias Hawila, Gizi Wildbaum, Jochen Utikal, Nathan Karin, Viktor Umansky - Cancer Research 2018 被引用: 176

  12. IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma

    著者: Rebekka Weber, Zeno Riester, Laura Hüser, Carsten Sticht, Alina Siebenmorgen, Christopher Groth, Xiaoying Hu, Peter Altevogt, Jochen Utikal, Viktor Umansky - Journal for ImmunoTherapy of Cancer 2020 被引用: 125

  13. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM

    著者: Steffen Runz, Sascha Keller, Christian Rupp, Alexander Stoeck, Yasmin Issa, Dominique Koensgen, Alexander Mustea, Jalid Sehouli, Glen Kristiansen, Peter Altevogt - Gynecologic Oncology 2007 被引用: 400

  14. Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma

    著者: Veronica Huber, Viviana Vallacchi, Viktor Fleming, Xiaoying Hu, Agata Cova, Matteo Dugo, Eriomina Shahaj, Roberta Sulsenti, Elisabetta Vergani, Paola Filipazzi, Angela De Laurentiis, Luca Lalli, Lorenza Di Guardo, Roberto Patuzzo, Barbara Vergani, Elena Casiraghi, Mara Cossa, Ambra V. Gualeni, Valentina Bollati, Flavio Arienti, Filippo de Braud, Luigi Mariani, Antonello Villa, Peter Altevogt, Viktor Umansky, Monica Rodolfo, Licia Rivoltini - Journal of Clinical Investigation 2018 被引用: 256

  15. Loss of EpCAM expression in breast cancer derived serum exosomes: Role of proteolytic cleavage

    著者: Anne-Kathleen Rupp, Christian Rupp, Sascha Keller, Jan C. Brase, Robert Ehehalt, Mina Fogel, Gerhard Moldenhauer, Frederik Marmé, Holger Sültmann, Peter Altevogt - Gynecologic Oncology 2011 被引用: 304

  16. Melanoma Extracellular Vesicles Generate Immunosuppressive Myeloid Cells by Upregulating PD-L1 via TLR4 Signaling

    著者: Viktor Fleming, Xiaoying Hu, Céline Weller, Rebekka Weber, Christopher Groth, Zeno Riester, Laura Hüser, Qian Sun, Vasyl S. Nagibin, Carsten J. Kirschning, Vincenzo Bronte, Jochen Utikal, Peter Altevogt, Viktor Umansky - Cancer Research 2019 被引用: 132

  17. STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice

    著者: Rebekka Bitsch, Annina Kurzay, Feyza Gül Özbay Kurt, Carolina De La Torre, Samantha Lasser, Alisa Lepper, Alina Siebenmorgen, Verena Müller, Peter Altevogt, Jochen Utikal, Viktor Umansky - Journal for ImmunoTherapy of Cancer 2022 被引用: 84

  18. HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling

    著者: Ihor Arkhypov, Feyza Gül Özbay Kurt, Rebekka Bitsch, Daniel Novak, Vera Petrova, Samantha Lasser, Thomas Hielscher, Christopher Groth, Alisa Lepper, Xiaoying Hu, Wei Li, Jochen Utikal, Peter Altevogt, Viktor Umansky - Journal for ImmunoTherapy of Cancer 2022 被引用: 38

  19. Exosomes: From biogenesis and secretion to biological function

    著者: Sascha Keller, Michael P. Sanderson, Alexander Stoeck, Peter Altevogt - Immunology Letters 2006 被引用: 856

  20. CD24 expression is a new prognostic marker in breast cancer.

    著者: Glen Kristiansen, Klaus‐Jürgen Winzer, Émpar Mayordomo, Joachim Bellach, Karsten Schlüns, Carsten Denkert, Edgar Dahl, Christian Pilarsky, Peter Altevogt, Hans Guski, Manfred Dietel - 2003 被引用: 307

  21. Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment

    著者: Kirsten De Ridder, Alexandra Sevko, Janina Heide, Maria Dams, Anne-Kathleen Rupp, Jadranka Macas, Julia Starmann, Marc Tjwa, Karl H. Plate, Holger Sültmann, Peter Altevogt, Viktor Umansky, Stefan Momma - OncoImmunology 2015 被引用: 276

  22. Body Fluid Exosomes Promote Secretion of Inflammatory Cytokines in Monocytic Cells via Toll-like Receptor Signaling

    著者: Niko P. Bretz, Johannes Ridinger, Anne-Kathleen Rupp, Katharina Rimbach, Sascha Keller, Christian Rupp, Frederik Marmé, Ludmila Umansky, Viktor Umansky, Tatjana Eigenbrod, Marei Sammar, Peter Altevogt - Journal of Biological Chemistry 2013 被引用: 247

  23. CD24 is a marker of exosomes secreted into urine and amniotic fluid

    著者: Sandro Keller, Christian Rupp, Alexander Stoeck, Steffen Runz, Mina Fogel, Sebastian Lugert, H. D. Hager, Mohamed S. Abdel‐Bakky, Paul Gutwein, Peter Altevogt - Kidney International 2007 被引用: 369

  24. Targeting CD24 for Treatment of Colorectal and Pancreatic Cancer by Monoclonal Antibodies or Small Interfering RNA

    著者: Eyal Sagiv, Alex Starr, Uri Rozovski, Rami Khosravi, Peter Altevogt, Timothy C. Wang, Nadir Arber - Cancer Research 2008 被引用: 163